Table 1.

Clinical and demographical characteristics of the OCD patients

Patient number/age (years)/gender (F/M)	Age at surgery (years)	Duration of disease before surgery (years)	Age at onset of OCD (years)	Duration of DBS (months)	YBOCS before surgery	YBOCS Baseline at time of study	Medications at the time of the study
1/46/M	39	18	21	71	37	25	Fluvoxamine 200 mg/day; Lorazepam 4 mg/day
2/49/F	42	25	17	64	30	28	Aripiprazole 30 mg/day; Olanzapine 5 mg/day; Escitalopram 20 mg/day; Clomipramine 75 mg/day
3/39/M	36	17	19	32	32	28	Paroxetine 60 mg/day
4/53/F	49	39	10	51	35	29	Fluoxetine 20 mg/day; Clomipramine 25 mg/day
5/37/M	34	13	21	22	32	27	Clomipramine 150 mg/day; Oxazepam 175 mg/day; Alimemazine 50 mg/day
6/41/F	38	11	27	35	36	6	None
7/43/F	40	15	25	32	36	23	Fluvoxamine 200 mg/day; Hydroxyzine 50 mg/day; Clomipramine 25 mg/day
8/41/F	37	5	32	44	32	2	Venlafaxine 37.5 mg/day; Clotiazepam1.5 mg/day
9/30/M	27	10	17	25	38	24	Sertraline 50 mg/day; Aripiprazole 20 mg/day; Methylphenidate 60 mg/day; Pitolisant 20 mg/day
10/56/F	52	25	27	51	40	18	Zopiclone 7.5 mg/day; Aripiprazole 2.5 mg/day; Hydroxyzine 100 mg/day
11/33/F	33	21	12	5	30	11	Venlafaxine 150 mg/day
12/33/F	33	26	7	25	34	19	Fluoxetine 20 mg/day; Levothyroxine 125 µg/day

M male, F female, YBOCS Yale Brown Obsessive–Compulsive Scale, DBS deep brain stimulation, OCD obsessive–compulsive disorder